Dr. Mark Oldendorf, MD Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 407 Albany Shaker Rd Ste 100, Loudonville, NY 12211 Phone: 518-435-1300 |
John Buddenhagen, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 407 Albany Shaker Rd, Loudonville, NY 12211 Phone: 518-435-1300 Fax: 518-435-1397 |
Nitin Jindal, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 407 Albany Shaker Rd Ste 100, Loudonville, NY 12211 Phone: 518-435-1300 |
News Archive
A minimally invasive device for treating recurrent stress urinary incontinence in women has been shown to be safe and effective in early clinical trials and is now under review by the U.S. Food and Drug Administration (FDA), says Emory University School of Medicine urologist and trial co-principal investigator Niall Galloway, MD.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
Omega-3 fatty acids are able to stimulate the activation of brown and beige adipose tissues, a discovery that would promote the development of new therapies for obesity and other metabolism diseases, according to a research study published in the journal Nature Communications under the supervision of Professor Francesc Villarroya, from the Department of Biochemistry and Molecular Biomedicine and the Biomedical Research Center Red-Fisiopatología de la Obesidad y Nutrición (CIBEROBN) of the Institute of Health Carlos III.
New research led by investigators at Memorial Sloan-Kettering Cancer Center (MSKCC) sheds light on a genetic function that gives breast cancer cells the ability to survive and spread to the bone years after treatment has been administered.
Barcelona, Spain: Trends indicate that survival is improving in patients with metastatic breast cancer, especially in those patients whose tumours are described as being HER2 (human epidermal growth factor receptor-2) positive, a surgical oncologist will say today at the seventh European Breast Cancer Conference (EBCC7).
› Verified 7 days ago